Stay updated with breaking news from Stent Infinite. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size, Share & Trends Analysis Report by Product (Valves, Glaucoma...
Operator: Hello, and welcome to Glaukos Corporation's Third Quarter 2023 Financial Results Conference Call.
Glaukos (NYSE:GKOS – Free Report) and NEXGEL (NASDAQ:NXGL – Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations and valuation. Institutional and Insider Ownership 97.5% of Glaukos shares are owned by institutional […]
The firm said investors are overlooking some "exciting" treatments ahead for glaucoma, corneal disorders and other retinal diseases.
Innovation finds its way into all areas of medtech, and ophthalmic treatments represent another burgeoning space.